Brief: Tianda Pharmaceuticals Enters Into Agreement With Zhong Ji Longevity Science Group
10/11/2021 01:12
Nov 10 (Reuters) - Tianda Pharmaceuticals Ltd 0455.HK :
* ENTERED INTO A STRATEGIC COOPERATION FRAMEWORK AGREEMENT
WITH
ZHONG JI LONGEVITY SCIENCE GROUP LIMITED
* PARTIES WILL JOINTLY EVALUATE & INVEST IN POTENTIAL
MEDICAL
TECHNOLOGY & MEDICAL SERVICE PROJECTS, AMONG OTHERS
Source text for Eikon: ID:nHKS4dwMm5
Further company coverage: 0455.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianda Pharmaceuticals
See all newsBrief: Tianda Pharmaceuticals Says Loss Attributable Expected To Increase To Hk$61 Million For FY
Brief: Tianda Pharmaceuticals Clarifies On Fraudulent Fund Raising Scams
Brief: Tianda Pharmaceuticals Sees Loss Attributable For Interim Period Increase To Not Less Than HK$27 Mln
Brief: Tianda Pharmaceuticals Says Unit Granted Drug Registration Approval Of Ibuprofen Suspension By NMPA
Brief: Tianda Pharmaceuticals Says Drug Registration Approval Of "Nicorandil For Injection" By NMPA